News

20 May 2026

Morning briefing: Impax Environmental completes exit tender, Baillie Gifford Japan seeks buyback authority renewal, BlackRock Energy and Resources Income benefits from energy transition and mining stocks, and HOME releases interims

Impax Environmental Markets (IEM) has completed its exit tender offer, repurchasing just over 148.2m shares, all of which will be cancelled. As previously announced, the scale of the tender – which was designed to give shareholders the opportunity to exit and avoid being trapped in a vehicle controlled by Saba Capital – dramatically shrinks the […]

01 May 2026
an excited crowd stares upward as Artemis 2 mission takes off

Seraphim C share issue injects life into the sector

A welcome revival of a long dormant structure It is no secret that the UK investment companies market has been shrinking for the past three years, with new capital raising proving difficult – if not impossible – in most cases. However, news of a Seraphim C share issue is injecting life into the investment companies […]

22 Apr 2026

Metage renews attack on Pantheon International, presses for stronger discount action

Metage Capital has published a fresh open letter to the board of Pantheon International (PIN), accusing the company of failing to respond adequately to concerns raised in December over performance, capital allocation and the persistent discount to net asset value (NAV) – click here to read. Metage said Pantheon has had several opportunities to address […]

22 Apr 2026

Government moves to curb gas-driven power price shocks; TRIG sees potential benefits

The UK government has unveiled a broad package of energy reforms aimed at reducing the influence of volatile gas prices on electricity bills, alongside fresh support for clean power, grid investment and electrification. The measures come as renewed geopolitical tensions and disruption in the Middle East have once again exposed the UK’s reliance on international […]

22 Apr 2026

Morning briefing: Impax Environmental Markets will engage constructively with Saba; plus AEET, MGCI

Impax Environmental Markets (IEM) has responded to the statement from Saba Capital yesterday that it holds 29.9% of the trust, saying that IEM’s tender offer remains on track, allowing shareholders who elected to tender to exit close to NAV. IEM’s board has reiterated that Saba did not confirm its tender elections ahead of the deadline, […]

27 Mar 2026

The landslide lady – is this Japan’s Thatcher moment?

A couple of months ago, I had the pleasure of sitting down with Nicholas Weindling, manager of JPMorgan Japanese (JFJ) as part of our ‘meet the manager’ podcast series (you can listen here). Our chat proved to be very timely as just three months into the job, Sanae Takaichi, Japan’s new and first ever female […]

13 Mar 2026

With much regret, Edinburgh Worldwide shareholders should take up the board’s 100% tender offer in full

This week, much to our disappointment, Edinburgh Worldwide (EWI) announced proposals for a 100% tender offer which, if enacted, would bring about the demise of the trust as we know it. On the face of it, the proposals appear to be a response to the ongoing attacks that EWI is facing from the New York-based […]

09 Jan 2026

Simply the BESS

Regular followers of QuotedData’s coverage of investment companies, and, increasingly ETFs, will hopefully know that, as each new year approaches, we ask each of our analysts to come up with a couple of stocks ideas for the year ahead. One is a relatively mainstream core investment idea, and the other is a spicier idea that […]

09 Jan 2026

Seraphim uplifted by ICEYE and HawkEye 360 as SpaceTech sector gathers pace

Seraphim Space (SSIT) has reported a strong end to 2025 across several of its core holdings, as the wider space technology sector continues to transition from speculative promise to commercial execution. The standout news came from ICEYE, which secured a landmark €1.7bn contract with the German Armed Forces via its joint venture with Rheinmetall. Alongside […]

09 Jan 2026

Morning briefing: Life Science REIT hit by valuation decline and yield pressures; Ruffer caps 2025 with double-digit gains and continues buybacks

Life Science REIT (LABS) has reported a 7.8% fall in its portfolio valuation over the second half of 2025, with its EPRA NTA per share declining by 13.0% over the same period. As at 31 December 2025, the portfolio was valued at £332.6m, down from £360.6m at 30 June 2025. The unaudited EPRA NTA stood […]